-
公开(公告)号:US20100261796A1
公开(公告)日:2010-10-14
申请号:US11919188
申请日:2006-04-26
CPC分类号: A61K31/17
摘要: The present invention relates to use of novel compounds for the manufacture of a medicament for treatment of inflammatory bowel disease (IBD) as well as to a method for treatment of IBD, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
摘要翻译: 本发明涉及新型化合物在制备用于治疗炎症性肠病(IBD)的药物中的用途以及用于治疗IBD的方法,其中所述化合物被给药。 化合物由通式(I)表示,如说明书中进一步定义的。